ClinicalTrials HQ

Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome

Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome

Active, not recruiting · NCT07228403 · Registry updated 2026-07-30
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel SyndromeDigestive System Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, intestinal disorder, malabsorption syndrome, metabolic disease, short bowel syndromeActive, not recruitingPhase 32026-07-30NCT07228403

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Zealand Pharma11

16 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AP-HP - Hôpital BeaujonClichyFrance1
Asklepios Klinik St. GeorgHamburgGermany8
Charité - Universitätsmedizin BerlinBerlinGermany18
Cleveland Clinic-9500 Euclid AveClevelandUnited States1
LHSC - University HospitalLondonCanada1
Lied Transplant Center at Nebraska Medical CenterOmahaUnited States2
Mayo Clinic - PPDSRochesterUnited States2
Samodzielny Publiczny Szpitala Kliniczny im. Prof. Witolda Orlowskiego CMKPWarsawPoland1
St Mark's Hospital (Central Middlesex Hospital)EalingUnited Kingdom1
Szpital Skawina sp. z o.o. im. Stanley DudrickaSkawinaPoland1
Universitätsklinikum BonnBonnGermany24
Universitätsklinikum FrankfurtFrankfurt am MainGermany8
Universitätsmedizin RostockRostockGermany3
UZ Leuven - PPDSLeuvenBelgium5
Vanderbilt University Medical Center-Tennesse-1211 21st Ave SNashvilleUnited States1
Wojewódzki Szpital Specjalistycznyo im. M. Pirogowa w LodziLodzPoland1